Market Research Assistance
- + 1-888-391-5441
- [email protected]
On the Web 
cancer therapeutics Market Research Reports
cancer therapeutics Market Research Reports
| Title | published | price | |
|---|---|---|---|
Chemotherapy Induced Myelosuppression Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key PlayersBy Global Markets Direct "...... hemotherapy Induced Myelosuppression pipeline landscape.
The report provides comprehensive information on the therapeutics under development for Chemotherapy Induced Myelosuppression, complete with analysis by Stage of Development, Drug ......" | 02-May-2022 | $2000 | |
Laryngeal Cancer Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key PlayersBy Global Markets Direct "......
The report provides comprehensive information on the therapeutics under development for Laryngeal Cancer, complete with analysis by Stage of Development, Drug Target, Mechanism of Action (MoA), Route of Administration (RoA) and Molecule Type. ......" | 02-May-2022 | $2000 | |
Oral Cavity (Mouth) Cancer Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key PlayersBy Global Markets Direct "...... cer pipeline landscape.
The report provides comprehensive information on the therapeutics under development for Oral Cavity (Mouth) Cancer, complete with analysis by Stage of Development, Drug Target, Mechanism of Action (MoA), Route of ......" | 02-May-2022 | $2000 | |
Thymic Carcinoma Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key PlayersBy Global Markets Direct "......
The report provides comprehensive information on the therapeutics under development for Thymic Carcinoma, complete with analysis by Stage of Development, Drug Target, Mechanism of Action (MoA), Route of Administration (RoA) and Molecule Type. ......" | 02-May-2022 | $2000 | |
T-Cell Acute Lymphocytic Leukemia (T-Cell Acute Lymphoblastic Leukaemia) Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key PlayersBy Global Markets Direct "...... MoA, RoA, Molecule Type and Key Players provides an overview of the T-Cell Acute Lymphocytic Leukemia (T-Cell Acute Lymphoblastic Leukaemia) pipeline landscape.
The report provides comprehensive information on the therapeutics under dev......" | 02-May-2022 | $2000 | |
Post-Essential Thrombocythemia Myelofibrosis (Post-ET MF) Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key PlayersBy Global Markets Direct "...... ey Players provides an overview of the Post-Essential Thrombocythemia Myelofibrosis (Post-ET MF) pipeline landscape.
The report provides comprehensive information on the therapeutics under development for Post-Essential Thrombocythemia M......" | 02-May-2022 | $2000 | |
Peripheral T-Cell Lymphomas (PTCL) Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key PlayersBy Global Markets Direct "...... ral T-Cell Lymphomas (PTCL) pipeline landscape.
The report provides comprehensive information on the therapeutics under development for Peripheral T-Cell Lymphomas (PTCL), complete with analysis by Stage of Development, Drug Target, Mech......" | 02-May-2022 | $2500 | |
Myeloproliferative Disorders Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key PlayersBy Global Markets Direct "...... Disorders pipeline landscape.
The report provides comprehensive information on the therapeutics under development for Myeloproliferative Disorders, complete with analysis by Stage of Development, Drug Target, Mechanism of Action (MoA), R......" | 02-May-2022 | $2500 | |
Colon Carcinoma Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key PlayersBy Global Markets Direct "...... />
The report provides comprehensive information on the therapeutics under development for Colon Carcinoma, complete with analysis by Stage of Development, Drug Target, Mechanism of Action (MoA), Route of Administration (RoA) and Molecule Type. The ......" | 02-May-2022 | $2000 | |
Chronic Myelomonocytic Leukemia (CMML) Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key PlayersBy Global Markets Direct "...... Chronic Myelomonocytic Leukemia (CMML) pipeline landscape.
The report provides comprehensive information on the therapeutics under development for Chronic Myelomonocytic Leukemia (CMML), complete with analysis by Stage of Development, D......" | 02-May-2022 | $2000 | |
| | |||